Sabcomeline
Introduction '''Sabcomeline''' ('''Memric'''; '''SB-202,026''') is a selective M1 receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.
See also * Alvameline* Milameline* Tazomeline* Xanomeline
References